| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.14 | 7e-06 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.18 | 4e-05 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |